Torisel is a treatment for advanced renal cell carcinoma (RCC).
- Torisel is the first mammalian target of rapamycin (mTOR) inhibitor for the treatment of advanced RCC.
- Mtor is a protein found inside the body’s cells that plays a role in cell growth and spanision.
- By inhibiting mTOR, Torisel blocks the processes through which both normal cells and cancerous kidney cells grow and spanide.
- Torisel may help stop the creation of new blood vessels that feed the advanced RCC cells.
Brand: Torisel 25mg
in section "Oncology Products"